INTRODUCTION
CD4 + T helper (T H ) cells play a central role in orchestrating adaptive immune response to pathogens and also contribute to autoimmune diseases (1, 2) . After antigen stimulation, naïve CD4 + T cells differentiate into discrete subsets of effector T H cells with distinct functions and cytokine profiles. Interferon-γ (IFN-γ)-producing T H 1 cells, induced by IL-12 and directed by transcriptional factor T-bet, are critical for the clearance of intracellular pathogens (3, 4) . T H 2 cells, which secrete IL-4, IL-5, and IL-13 and are controlled by GATA-3, are crucial for protection against parasites and extracellular pathogens (5, 6) . T H 17 cells produce IL-17A, IL-17F, and IL-22, and play an important role in the control of specific pathogens such as fungi. T H 17 differentiation is driven by a combination of TGF-β and IL-6 and requires transcriptional factor RORγt and RORα. IL-23 promotes T H 17 responses by enhancing their survival and stabilization (7) (8) (9) (10) (11) (12) .
Despite their importance in host immunity against pathogens, T H cells can be pathogenic and contribute to various diseases. Both exaggerated and defective T H 1 response has been linked to the induction of autoimmune diseases (13) (14) (15) . T H 2 cells contribute to allergies and asthma (16, 17) . T H 17 cells are associated with many autoimmune and inflammatory diseases such as psoriasis, inflammatory bowel diseases, rheumatoid arthritis, type 1 diabetes, and multiple sclerosis (8, 11, (18) (19) (20) . Thus, understanding how T H responses are regulated is important to manipulate immune responses, to improve host defense against microbial infection, and to treat autoimmune diseases.
Engagement of the TCR on naïve CD4 + T cells is essential for their activation and further differentiation to T H cells (21, 22) . Evidence has revealed that TCR signal strength and downstream signaling pathways as well as cytokine and costimulatory signals shape T H lineage differentiation (23) (24) (25) (26) . A critical event after TCR engagement is the generation of the second messenger diacylglycerol (DAG) by activated PLCγ1. DAG associates with and allosterically activates RasGRP1 and PKCθ, leading to the activation of the Ras-Erk1/2-AP1 and PKCθ-IKK-NFκB signaling pathways, respectively, and is indispensable for T cell activation (27) (28) (29) (30) . Since it has been demonstrated that both Ras-and PKCθ-mediated signal cascades are involved in T H differentiation (31) (32) (33) (34) , it is important to investigate if DAG concentrations should be tightly controlled during T H differentiation.
DAG kinases (DGKs), a family of enzymes that catalyze phosphorylation of DAG to generate phosphatidic acid (PA), are employed to inhibit DAG-mediated signaling following TCR engagement in both thymocytes and peripheral T cells (28) (29) (30) . DGKα and ζ, isoforms that express at high levels in T cells, have been demonstrated to inhibit the activation of both Ras-Erk and PKCθ-NFκB cascades as well as mTOR signaling (35) (36) (37) . They regulate conventional αβT cell, iNKT cell, mucosal associated invariant T cell, and regulatory T cell development, negatively control T cell activation, regulate CD8 T cell mediated anti-viral responses and activation induced T cell death, promote T cell anergy, and inhibit anti-tumor responses (27, (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) . However, the role of DGKs in T H differentiation is unknown. We report here that a deficiency of either DGKα or ζ selectively impairs T H 1 cell differentiation, but the loss of both DGK isoforms enhances CD4 + naïve T cells differentiating into T H 1 and T H 17 in vitro and in vivo, establishing DGK activity as a critical regulator of effector CD4 + T cell differentiation.
MATERIALS AND METHODS

Mice
DGKα −/− , DGKζ −/− , and ERCre mice were generated as previously described (38, 39, 56) . DGKζ f /f mice were generated by introducing two LoxP sites that flank exons 10-14 of the Dgkz locus (57) . TCR transgenic OT2 mice were purchased from the Jackson Laboratory and were cross-bred with DGKα −/− ζ f/f ERCre mice to generate DGKα −/− ζ f/f OT2 ERCre mice in specific pathogen-free facilities at Duke University Medical Center. The experiments in this study were performed according to a protocol approved by the Institutional Animal Care and Usage Committee of Duke University. DGKα −/− ζ f/f or DGKα −/− ζ f/f OT2 ERCre mice were intraperitoneally injected with tamoxifen (100 mg/kg body weight) on the first, second, and fifth day to delete DGKζ, and mice were then euthanized for experiments on the eighth day.
Reagents and Antibodies
Iscove's modified Dulbecco's medium (IMDM) was supplemented with 10% (vol/vol) FBS, penicillin/streptomycin, and 50 µM 2-mercaptoethanol (IMDM-10). Fluorescenceconjugated anti-mouse antibodies CD4 (GK1.5), TCRVα2 (B20.1), CD44 (IM7), CD62L (MEL-14), Thy1.1 (OX-7), Thy1.2 (58-2.1), T-bet (4B10), IFN-γ (XMG1.2), IL-4 (11B11), IL-17A (TC11-18H10.1), and IL-17F (9D3.1C8) were purchased from BioLegend; anti-mouse antibodies for RORγt (AFKJS-9) and Foxp3 (FJK-16s) were purchased from eBioscience. Cell death was determined by Live/Dead Fixable Violet Dead Cell Stain (Invitrogen).
Flow Cytometry
Standard protocols were used to prepare single cell suspensions from the spleen and lymph nodes of mice (in IMDM containing 10% FBS and antibiotics). Red blood cells were lysed using an ACK buffer. Samples were subsequently stained with antibodies in PBS containing 2% FBS and collected on a BD FACSCanto II cytometer. Intracellular staining for T-bet and RORγt was performed using the eBioscience Foxp3 Staining Buffer Set. Intracellular staining for IFNγ, IL-4, IL-17A, and IL-17F was performed using the BD Biosciences Cytofix/Cytoperm and Perm/Wash solutions.
In vitro T H Differentiation
CD4 + T cells were purified from the spleen and LN with anti-CD4 microbeads (Miltenyi Biotec) and then were further sorted as naïve CD4 + CD62L hi CD44 lo CD25 − . Sorted cells were activated with plate-bound anti-CD3 (5 µg/ml, 1452C11, Bio Xcell) and soluble anti-CD28 (1 µg/ml, PV1, BioXcell) for 4-5 days with various combinations of cytokines and antibodies. For the non-polarizing (T H 0) condition, naïve cells were cultured in the presence of hIL-2 (100 U/ml, Peprotech). For the T H 1 condition, naïve cells were cultured with hIL-2 (100 U/ml), mIL-12 (20 ng/ml, Peprotech), and anti-mIL4 (10 µg/ml, 11B11, Bio Xcell) for 4 days. For the T H 2 condition, naïve cells were polarized in the presence of hIL-2 (100 U/ml), mIL-4 (20 ng/ml, Peprotech), and anti-IFNγ (10 µg/ml, XMG1.2, BioXcell) for 5 days. For the T H 17 condition, naïve cells were cultured with hTGF-β1 (5 ng/ml, Peprotech), mIL-6 (25 ng/ml, Peprotech), anti-mIL4 (10 µg/ml), and anti-IFNγ (10 µg/ml) for 4 days. For iTreg induction, 100 U/ml of hIL-2 and 1 ng/ml TGFβ (Peprotech) were included in the culture for 4 days, followed by intracellular Foxp3 staining. To assess proliferation, sorted naïve CD4 + T cells were labeled with CellTrace TM Violet (CTV, ThermoFisher) before cultured in different polarization conditions. For the inhibition assay, 10 µM S6K inhibitor (PF-4708671, Sigma) and 1 nM rapamycin were added to the T H 1 and T H 17 polarizing conditions at the beginning of culture, and cells were cultured for 4 days. At the end of polarizing, cells were stimulated with PMA (50 ng/ml) and ionomycin (500 ng/ml) in the presence of GolgiPlug (1 ng/ml) for 4-5 h. This was followed by cell surface and intracellular staining for appropriated cytokines.
Adoptive Transfer, Immunization, and Airway Inflammation For airway inflammation, OTII T cell recipient mice were intranasally injected with 25 µl of 2.5 mg/ml OVA 323−339 peptide in PBS daily for 3 consecutive days starting 24 h after adoptive transfer. Mice were euthanized on the eighth day after adoptive transfer for collection of BALF. Lungs were fixed in 10% formalin and thin-sectioned for hematoxylin and eosin (H&E) staining. Spleen and draining mediastinal LNs were harvested for cytokine analysis.
ELISA
Cultured supernatant or BALF samples were appropriately diluted and IFNγ, IL-4, and IL-17A concentrations were determined using Mouse ELISA max kits (BioLegend) according to the manufacturer's instructions.
Real-Time RT-PCR
Cells were lysed in Trizol for RNA preparation. The first strand cDNA was made using the iScript Select cDNA Synthesis Kit (Biorad). Real-time quantitative PCR was conducted using Eppendorf realplex 2 . Expressed levels of target mRNAs were normalized with β-actin and calculated using the 2 − CT method. Primers used in this study are listed as following: 
Western Blot Analysis
In vitro-cultured T H cells were lysed in lysis buffer (1% Nonidet P-40, 150 mM NaCl, 50 mM Tris, pH 7.4) with freshly added protease and phosphatase inhibitors. Samples were subjected to immunoblotting analysis, and probed with anti-pS6 (S235/236), -pErk1/2, -total S6, -total Erk1/2, and β-actin antibodies (Cell Signaling Technology).
Statistical Analysis
Data are presented as mean ± SEM, and statistical significance was determined by two-tailed Student's t-test. The p-values are defined as follows: * p < 0.05, * * p < 0.01, * * * p < 0.001.
RESULTS
Deficiency of Either DGKα or ζ Impaired T H 1 Cell Differentiation
DGKα and ζ are dynamically regulated during T cell development and activation (27, 35, 39, 40) . We found that DGKα mRNA was decreased in T H 0, T H 
Deficiency of Both DGKα and ζ Promoted T H 1 and T H 17 Differentiation
DGKα and ζ promote T cell and iNKT cell maturation synergistically in the thymus (52, 54) . To determine if DGKα and ζ exert a synergistic role during T H differentiation, we generated DGKα −/− ζ f/f -ERCre (DKO) mice so that both DGKα and ζ were ablated after tamoxifen-induced deletion of DGKζ. In contrast to DGKα or ζ single-knockout T cells, DKO CD4 + naïve T cells showed enhanced capacity to differentiate into both T H 1 and T H 17 cells but similar T H 2 differentiation compared with their WT counterparts (Figures 2A,B) , coinciding with increased IFN-γ and IL-17A but not IL-4 concentration in culture supernatants ( Figure 2C ) and IFN-γ and IL-17A mRNA levels in these cells ( Figure 2D ). DKO CD4 + T cells displayed slightly decreased survival rate under T H 1 but similar survival rate under T H 17 polarization conditions, suggesting that their enhanced T H 1 and T H 17 responses were not due to improved survival ( Figure 2E) . T cells proliferated more vigorously than WT controls, which might contribute to their enhanced T H 1 and T H 17 responses (Figure 2F ). In contrast to T H 1 and T H 17 differentiation, iTreg cell induction was not obviously different between WT and DKO naïve CD4 + T cells (WT iTreg percentages: 62.49 ± 9.186 n = 7; DKO iTreg percentages: 53.84 ± 8.465 n = 7; P = 0.5022). Together, these results indicated that deficiency of both DGKα and ζ promoted T H 1 and T H 17 differentiation with minimal effects on T H 2 or iTreg cell differentiation in vitro.
Loss of Both DGKα and ζ Prompted T H 1 and T H 17 Differentiation in vivo
To further determine the impact of DGKα and ζ double deficiency on T H differentiation in vivo, we generated DKO mice carrying the OT2 TCR transgene, which recognizes chicken ovalbumin peptide 323-339 (OVA 323−339 ) in the context of I-A b (58) and adoptively transferred WT-or DKO-naïve OT2 T cells (Thy1.1 − Thy1.2 + CD4 + TCRVα2 + ) into congenic Thy1.1 + Thy1.2 + recipients. Recipient mice were immunized with OVA 323−339 peptide emulsified in complete Freund's adjuvant (CFA) 1 day after the transfer. Seven days after immunization, donor-derived DKO OT2 T cells were increased in both percentages and numbers in the spleen and draining lymph nodes (dLNs) compared with WT controls (Figures 3A-C) . In addition, higher percentages of DKO OT2 T cells expressed IFN-γ, IL-17A, and IL-17F than WT controls following in vitro PMA and ionomycin stimulation for 4 h (Figures 3D-F) . Because of increased DKO OT2 T cell numbers, DKO OT2 T H 1 and T H 17 cell numbers were much greater than WT controls in dLNs and particularly in the spleen (Figures 3G,H) . Moreover, DKO OT2 T cells contained more IFN-γ-, IL-17A-, and IL-17F-positive cells, which was detected by intracellular staining (Figures 3I,J) , and secreted more cytokines to culture supernatants, which was detected by ELISA ( Figures 3K,L) , than their WT controls following stimulation with OVA 323−339 peptide for 2 days. Together, these results demonstrated that the deficiency of both DGKα-and ζ-enhanced T H 1 and T H 17 polarization and expansion in vivo via cell intrinsic mechanisms.
Accumulation of T H 1 and T H 17 Cells in the Absence of DGKα and ζ Caused Severe Airway Inflammation
T H 17 cells promote airway inflammation and hyperresponsiveness via recruiting neutrophils and induce airway smooth muscle contraction, which contributes to the severe form of asthma (59, 60) . To determine if dysregulated T H responses of DKO CD4 + T cells impact airway inflammation, we adoptively transferred naïve WT and DKO OT2 cells (Thy1.2 + ) into WT Thy1.1 + Thy1.2 + congenic mice on day −1 and then intranasally injected OVA 323−339 peptide into the recipient mice on days 0, 1, and 2. On the seventh day, we detected at least four-fold more DKO OT2 cells in both percentages and numbers in the draining mediastinal lymph nodes and spleen in recipient mice than their WT counterparts (Figures 4A-C) . DKO donor-derived OT2 cells in both dLNs and spleens produced more IL-17A and IL-17F as well as IFN-γ in response to in vitro stimulation with PMA and ionomycin for 4 h (Figures 4D-H) or with OVA 323−339 peptide for 2 days (Figures 4I-M) . Concordantly, both IFN-γ and IL-17A levels in bronchoalveolar lavage fluid (BALF) were elevated in recipients with DKO OT2 T cells compared with those with WT OT2 T cells ( Figure 5A) . Moreover, DKO OT2 cell recipients contained more neutrophils and lymphocytes than those with WT control in BALF (Figures 5B,C) and in interstitial lung tissues that surround the bronchioles ( Figure 5D) . Together, these results demonstrated that DGKα and ζ deficiencies in CD4 + T cells exacerbated airway inflammation, likely as a result of enhanced T H 17 responses to protein allergens.
Effects of DGKαζ Double Deficiency on Expression of Critical Lineage Transcription Factors
T-bet, GATA-3, RORγt, and RORα are transcription factors that play critical roles in T H 1, T H 2, and T H 17 differentiation, respectively. Under the T H 1 polarization condition, DKO CD4 + T cells expressed higher levels of T-bet at both mRNA and protein levels than WT controls (Figures 6A,B) , which was consistent with their elevated T H 1 responses. In contrast, GATA-3 expression in DKO CD4 + T cells was not obviously different from WT controls under the T H 2 polarization condition (Figure 6C ), consistent with a minimal effect of DKO on T H 2 responses as shown in Figure 2 . Interestingly, Rorc (gene encoding RORγt) mRNA levels were obviously decreased in DKO CD4 + T cells under the T H 17 polarization condition (Figure 6D) , although RORγt protein was only slightly decreased ( Figure 6E) . In contrast, RORa mRNA levels were increased in DKO CD4 + T cells 24 and 36 h after polarization ( Figure 6F) . Both RORα and RORγt are important for T H 17 representative of or calculated from two independent experiments (n = 8). *P < 0.05; **P < 0.01; ***P < 0.001 as determined by the Student t-test.
FIGURE 5 | DGKαζDKO-exacerbated CD4
+ T cell-mediated airway inflammation. The same WT and DKO OT2 T cell recipient mice intranasally injected with OVA in Figure 4 were utilized to collect BALF and lung tissues. 
Effects of DGKα and ζ Double Deficiency on mTORC1/S6K1 Signaling During T H 1 and T H 17 Cell Differentiation
DGKα and ζ negatively control DAG-mediated Ras-Erk1/2 activation in thymocytes and naïve T cells following TCR engagement (36, 38, 54) . We further examined how DGKα and ζ double deficiency might affect this pathway during T H polarization. As shown in Figure 7A , Erk1/2 phosphorylation was obviously enhanced in DKO CD4 + T cells under T H 0, T H 1, T H 2, and T H 17 conditions, suggesting that DGKα and ζ negatively controlled Erk1/2 activation during effector CD4 + T cell differentiation. Previous studies have found that DAGmediated RasGRP1-Ras-Erk, PI3K-Akt, and PKCθ-CARMA1 pathways participate in TCR-induced mTORC1 activation and DGKα and ζ double deficiency but not DGKα or ζ single deficiency leads to enhanced mTOR signaling in developing thymocytes (36, 64, 65) and that mTOR plays important roles in Th differentiation (65) (66) (67) (68) (69) . Although, S6 phosphorylation, an mTORC1/S6K1-dependent event, in T H 1 cells appeared unaffected by DGKα and ζ double deficiency, it was obviously (Figures 7B,C) , suggesting that additional mechanisms might contribute to enhanced T H 1 differentiation in these cells. In contrast, T H 17 differentiation of both DKO and WT CD4 + T cells was potently inhibited by either rapamycin or PF-4708671 (Figures 7D,E) . Although, we could not rule out potential off-target effects of PF-4708671 and rapamycin, our data suggested that enhanced mTORC1/S6K1 signaling might contribute to the elevated T H 17 responses of DKO CD4 + T cells.
DISCUSSION
Previous studies have demonstrated that DGKα and ζ play crucial roles in T cell development, activation, anergy, and survival, and CD8 T cell-mediated anti-viral immune responses, iNKT cell development, regulatory T cell differentiation, and anti-tumor immune responses (27, (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) . Additionally, DGKζ has been found to regulate B cell development (70) , mast cell activation (71), TLR-mediated innate immunity (72) , and NK cells (73) . In this study, we have demonstrated that graded DGK activities differentially control CD4 + T H differentiation. Although, the absence of either DGKα or ζ selectively impairs T H 1 differentiation, simultaneous ablation of both DGKα and ζ enhances both T H 1 and T H 17 responses in vitro and in vivo.
Recent studies have demonstrated that mTOR signaling plays a critical role in T cell activation and T H differentiation. mTORC1 promotes T H 1, T H 2, and T H 17 differentiation while mTORC2 activity is indispensable for T H 2 cells development (65) (66) (67) . Among different effector CD4 + T cells, T H 1 cells appear to possess the highest S6 phosphorylation and, thus, mTORC1 activity. Although, S6 phosphorylation is not increased in DKO T H 1 cells, elevated DKO T H 1 response is substantially decreased when mTORC1-S6K1 signaling is inhibited, suggesting that enhanced DKO T H 1 response is at least in part via enhanced mTORC1-S6K1 signaling. Different from T H 1 cells, DKO T H 0, T H 2, and T H 17 cells contain elevated S6 phosphorylation, and inhibition of either mTORC1 or S6K1 reverts their elevated T H 17 responses. Our study suggested a linkage between DGKs and mTORC1/S6K1 in the regulation of T H 17 cell differentiation. In thymocytes, T cell line models, and primary T cells, both RasGRP1-Ras-Erk1/2 and PKCθ-CARMA1 pathways signal to promote mTORC1 activation (36, 64) . Although, it remains to be defined, DGKα and ζ may inhibit mTORC1/S6K1 signaling via modulating these DAG-mediated signaling pathways during effector CD4 + T cell differentiation. In addition to S6K1, many other molecules and pathways that play important roles in T H differentiation are regulated by mTOR (65, 68, 69, (74) (75) (76) (77) . Future studies should investigate whether DGKα and ζ may regulate T H differentiation through other mechanisms.
Dysregulated T H 1 and T H 17 responses contribute to the pathogenesis of numerous autoimmune diseases, including psoriasis, inflammatory bowel disease, rheumatoid arthritis, type 1 diabetes, multiple sclerosis, experimental autoimmune encephalomyelitis, and neutrophil-related airway inflammation (8, 11, (13) (14) (15) (18) (19) (20) . We have shown that dysregulated T H 1 and T H 17 responses in the absence of DGKα and ζ are pathogenic, indicated by exacerbated neutrophil-related airway inflammation. Interestingly, DGKα and ζ double deficiency leads to a loss of T cell tolerance and the development of autoimmune diseases in mice (manuscript in preparation). Enhanced CD4 + T cell effector function might be an important contributor to the development of autoimmune diseases in these mice. Thus, modulating DGKα and ζ activity could be a potential strategy to shape immune responses. Of note, although DGKα and ζ double deficiency does not obviously affect iTreg induction in vitro, our data do not rule out a potential role of DGK activity in peripheral Treg induction from naïve CD4 + T cells in vivo. Additional studies are needed to determine whether DGKα and ζ play a redundant role in Treg cells.
In summary, DGK activity plays selective roles in T H cell differentiation. A single knockout of DGKα or ζ impaired T H 1 cell differentiation whereas a deficiency of both DGKα and ζ promoted T H 1 and T H 17 cell differentiation in vitro and in vivo. Such dysregulated expansion of both T H cells in the absence of DGKα and ζ caused severe airway inflammation. DGKα and ζ double deficiency led to enhanced mTORC1-S6K1 activation during T H 17 cell differentiation, which may contribute to enhanced T H 17 cell differentiation. Our study demonstrated the role of DGKs in T H cell differentiation and provides useful evidence for these enzymes as potential targets for therapeutic approaches of autoimmune diseases associated with the dysregulation of T H 1 and T H 17 cells.
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